Home > Insider Trading > Filing (0001178913-11-002766)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1176309	Oramed Pharmaceuticals Inc.	ORMP.OB	Pharmaceutical Preparations (2834)	980376008

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1416089	Leonard Sank	3 Blair Road Cape Town T3 8005		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2011-10-04	937,500	$0.32	937,500	No	4	P	Indirect	Via spouse

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	Via spouse

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Warrant (right to buy)	Acquisiton	2011-10-04	328,125	$0.00	0	$0.50

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
328,125	2011-01-25	2016-01-25	No	4	A	Indirect

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	500,000	Indirect	Via trust
Common Stock	2,357,650	Direct

Footnotes

The 937,500 shares of Common Stock and the warrant to purchase 328,125 shares of Common Stock were purchased in January 2011 on behalf of a company wholly owned by a trust of which the Reporting Person is a trustee and 30% of the beneficiaries are members of the Reporting Person's immediate family. Accordingly, the Reporting Person may be deemed to have acquired indirect beneficial ownership of 30% of such securities when they were acquired by such company. The Reporting Person disclaims such beneficial ownership.
These shares represent 30% of the shares owned by a company wholly owned by a trust of which the Reporting Person is a trustee and 30% of the beneficiaries are members of the Reporting Person's immediate family. Accordingly, the Reporting Person may be deemed to have indirect beneficial ownership of these shares. The Reporting Person disclaims such beneficial ownership.